Compound Detail
CHEMBL2024212
GSK-625433 Phase I
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Phase I
COC[C@H]1C[C@@](Cn2cccn2)(C(=O)O)N(C(=O)c2ccc(C(C)(C)C)c(OC)c2)[C@H]1c1nccs1
Basic Information
| ChEMBL ID | CHEMBL2024212 |
| Name | GSK-625433 |
| Phase | Phase I |
| Structure Type | MOL |
| InChI Key | HLQXYDHLDZTWDW-KAWPREARSA-N |
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
1
Publications
1
Known Names
Molecular Properties
512.6
MW (Da)
4.02
ALogP
8
HBA
1
HBD
106.8
PSA (Ų)
0.49
QED
1
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Racemic |
Activity Summary
EC50 2 meas. best 8.7
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Hepatitis C virus CHEMBL379 | EC50 | 8.7 | 7.62 | 2.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Hepatitis C virus | EC50 | = | 2.0 | nM | 8.7 | Antiviral activity against Hepatitis C virus genotype 1b assessed as inhibition ... | 22516671 |
| Hepatitis C virus | EC50 | = | 290.0 | nM | 6.54 | Antiviral activity against Hepatitis C virus genotype 1a assessed as inhibition ... | 22516671 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 22516671 | 10.1016/j.bmc.2012.03.049 | Hepatitis C virus | 2 |
Data from ChEMBL 36 via Core Engine